期刊文献+

CT导向下^(125)I粒子植入治疗复发性盆腔恶性肿瘤 被引量:22

CT guided ^(125)I radioactive seeds implantation in the treatment of recurrent malignant pelvic tumors
下载PDF
导出
摘要 目的探讨CT导向下125I粒子植入治疗复发性盆腔恶性肿瘤的疗效。方法18例复发性盆腔恶性肿瘤患者采用CT导向下125I放射性粒子植入。粒子植入之前采用TPS模拟布源或遵循Halarism的125I经验公式:mCi=Da×5,Da为靶组织长、宽、高的平均值(L+W+H)/3,单位为cm,求出术中所需125I粒子的总活度及算出治疗粒子的数量。在螺旋CT导向下将125I放射性粒子植入盆腔肿瘤内。结果全组18例22个病灶治疗后2个月后采用PET-CT评价,完全缓解(CR)6例,部分缓解(PR)8例,稳定(NC)3例,进展(PD)1例。18例随访7~16个月,全部存活,近期平均生存期9.5个月。结论125I放射性粒子植入是治疗复发性盆腔恶性肿瘤的一种有效的方法。 Objective To explore the clinical efficacy of CT guided ^125Ⅰ seeds implantation in the treatment of recurrent malignant pelvic tumors. Methods Eighteen patients with recurrent malignant pelvic tumors were treated by spiral CT guided ^125Ⅰ radioactive seeds implantation according to the treatment planning system (TPS) or the Halarism's experienced function ( mCi = Da × 5). Resnlts All the 18 patients (22 lesions) were evaluated with PET-CT examinations two months after the treatment. Complete remission (CR), partial remission (PR), no change (NC), and progress disease (PD) were seen in 6, 8, 3, and 1 patient, respectively. All the patients survived, with a follow-up duration of 7 - 16 months. The average survival time was 9.5 months. Conclusions ^125Ⅰ radioactive seeds implantation is an effective method in the treatment of recurrent malignant pelvic tumors.
出处 《中国微创外科杂志》 CSCD 2007年第2期127-129,共3页 Chinese Journal of Minimally Invasive Surgery
基金 广东省科委课题资助(2006B35802009)
关键词 肿瘤 放射性粒子 Tumor Radioactive seed
  • 相关文献

参考文献8

  • 1李孟达.宫颈复发癌的诊断和治疗[J].实用妇产科杂志,1994,10(5):242-244. 被引量:15
  • 2Temple WJ,Saettler EB.Locally recurrent rectal cancer:role of composite resection of extensive pelvic tumors with strategies for minimizing risk of recurrence.Surg Oncol,2000,73(1):47-58.
  • 3Hong JH,Tsai CS,Lai CH,et al.Recurrent squamous cell carcinoma of cervix after definitive radiotherapy.Int J Radiat Oncol Biol Phys,2004,60(1):249-257.
  • 4Moore DH,Blessing JA,McQuellon RP,et al.Phase Ⅲ study of cisplatin with or without paclitaxel in stage IVB,recurrent,or persistent squamous cell carcinoma of the cervix:a gynecologic oncology group study.J Clin Oncol,2004,22(15):3113-3119.
  • 5Tsuda H,Hashiguchi Y,Nishimura S,et al.Phase Ⅰ-Ⅱ study of irinotecan (CPT-11) plus nedaplatin (254-S) with recombinant human granulocyte colony-stimulating factor support in patients with advanced or recurrent cervical cancer.Br J Cancer,2004,91(6):1032-1037.
  • 6Nag S,Ellis RJ,Merrick GS,et al.American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapy.Int J Radiat Biol Phys,2002,54(2):462-470.
  • 7Sharma SK,Forgione H,Isaacs JH.Iodine-125 interstitial implants as salvage therapy for recurrent gynecologic malignancies.Cancer,1991,67(10):2467-2471.
  • 8Hockel M,Sclenger K,Hamm H,et al.Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall.Cancer,1996,77(9):1918-1933.

共引文献14

同被引文献188

引证文献22

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部